Publication at Second Faculty of Medicine |
2018
Abstract
Gliflozins expanded therapeutic options for type 2 and 1 diabetes and also improved prevention and treatment of heart failure in patients with diabetes. Gliflozins in the diabetes treatment should be chosen individually and their mechanism of action should be always considered.
Effect of gliflozins is significant especially in the patients with more serious hyperglycaemia. Benefits from the gliflozins can be also seen in the heart failure prevention as they could be used as a part of secondary prevention in the need of intensified therapy.